We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Liberty Global Class C
LBTYK
$3.5B
| $361K | ﹤0.01% |
16,810
-23,881
| -59% | -$477K |
|
852
Bio-Techne
TECH
$11.2B
| $361K | ﹤0.01% |
5,476
+2,952
| +117% | +$177K |
|
|
AY
853
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $360K | ﹤0.01% |
12,405
-2,620
| -17% | -$66K |
|
854
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $357K | ﹤0.01% |
10,340
+4,020
| +64% | +$137K |
|
855
FirstService
FSV
$6.55B
| $354K | ﹤0.01% |
3,515
+2,725
| +345% | +$242K |
|
856
Azenta
AZTA
$1.3B
| $353K | ﹤0.01% |
7,998
-1,863
| -19% | -$71.3K |
|
857
Boston Scientific
BSX
$68.4B
| $353K | ﹤0.01% |
10,094
+4,583
| +83% | +$165K |
|
858
MSC Industrial Direct
MSM
$6.76B
| $353K | ﹤0.01% |
4,852
+3,876
| +397% | +$250K |
|
859
Invesco Large Cap Growth ETF
PWB
$2.17B
| $352K | ﹤0.01% |
6,442
-200
| -3% | -$10.1K |
|
860
iShares Global 100 ETF
IOO
$8.62B
| $351K | ﹤0.01% |
6,654
-553
| -8% | -$27.6K |
|
861
AvalonBay Communities
AVB
$27.5B
| $350K | ﹤0.01% |
2,274
+15
| +0.7% | +$2.37K |
|
862
LeMaitre Vascular
LMAT
$2.37B
| $350K | ﹤0.01% |
13,280
+11,210
| +542% | +$293K |
|
863
Nuveen Select Tax-Free Income Portfolio
NXP
$898M
| $348K | ﹤0.01% |
+22,195
| New | +$336K |
|
|
IAA
864
DELISTED
IAA, Inc. Common Stock
IAA
| $345K | ﹤0.01% |
8,945
-9,106
| -50% | -$340K |
|
865
Brown-Forman Class A
BF.A
$13.7B
| $344K | ﹤0.01% |
5,998
-300
| -5% | -$17.5K |
|
866
MaxLinear
MXL
$5.19B
| $344K | ﹤0.01% |
16,033
+15,538
| +3,139% | +$268K |
|
867
Sarepta Therapeutics
SRPT
$1.64B
| $340K | ﹤0.01% |
2,128
+19
| +0.9% | +$2.59K |
|
868
State Street SPDR S&P Homebuilders ETF
XHB
$1.61B
| $338K | ﹤0.01% |
7,737
+204
| +3% | +$7.74K |
|
869
Hasbro
HAS
$13.5B
| $337K | ﹤0.01% |
4,524
+880
| +24% | +$63.7K |
|
870
Lamb Weston
LW
$7.42B
| $337K | ﹤0.01% |
5,307
-164
| -3% | -$9.9K |
|
|
HOLX
871
DELISTED
Hologic
HOLX
| $334K | ﹤0.01% |
5,866
+1,472
| +34% | +$72.2K |
|
|
EPAY
872
DELISTED
Bottomline Technologies Inc
EPAY
| $333K | ﹤0.01% |
6,575
+3,900
| +146% | +$174K |
|
873
Keurig Dr Pepper
KDP
$42.8B
| $332K | ﹤0.01% |
11,728
+589
| +5% | +$16K |
|
874
Casella Waste Systems
CWST
$5.76B
| $330K | ﹤0.01% |
6,350
+4,710
| +287% | +$225K |
|
875
W.P. Carey
WPC
$16.6B
| $328K | ﹤0.01% |
4,970
-55
| -1% | -$3.42K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.